gamma-butyrobetaine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Svalbe, B | 1 |
| Zvejniece, L | 1 |
| Vavers, E | 1 |
| Pugovics, O | 1 |
| Muceniece, R | 1 |
| Liepinsh, E | 1 |
| Dambrova, M | 1 |
1 other study available for gamma-butyrobetaine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats.
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Betaine; Brain Infarction; Carnitine; Chromat | 2011 |